The 20 Best Monoclonal Gammopathy of Undetermined Significance (MGUS) Doctors Near Me in New Jersey, US

Neha Korde is a Hematologist and an Oncologist practicing medicine in Montvale, New Jersey. Dr. Korde is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Korde is currently accepting new patients.

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Morganstein is board certified in American Board Of Internal Medicine. Dr. Morganstein is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration. Dr. Scola is board certified in American Board Of Internal Medicine. Dr. Scola is currently accepting new patients.

David Siegel is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, and Schnitzler Syndrome. Dr. Siegel is board certified in American Board Of Internal Medicine.

David Vesole is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Vesole is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine.

Noa Biran is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Biran is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Plasmacytoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Biran is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

Stephen Wallace is an Oncologist practicing medicine in Mount Holly, New Jersey. Dr. Wallace is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Colorectal Cancer, Familial Colorectal Cancer, and Pleuropulmonary Blastoma.

Noah Lindenberg is a Hematologist and a Hematologist Oncology provider practicing medicine in Marlton, New Jersey. Dr. Lindenberg is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Familial Colorectal Cancer, and Lung Cancer. Dr. Lindenberg is board certified in Oncology and Hematology. Dr. Lindenberg is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.

Ashish Khot, MD, is a fellowship-trained physician specializing in hematology/oncology with Atlantic Medical Group (AMG). Board-certified in hematology and medical oncology by the American Board of Internal Medicine, he has clinical expertise in diagnosing and treating blood disorders including anemia, leukemia, lymphoma and cancers of various organs, particularly lung, genitourinary, gastrointestinal and thoracic malignancies.Dr. Khot embraces a patient-centric approach, educating and empowering his patients and their families to make well-informed decisions regarding their health care. He strongly believes in fostering open communication among patients, their caregivers, and all collaborating physicians, ensuring that their care remains seamlessly coordinated throughout their challenging medical journeys.After earning his medical degree at Grant Medical College in Mumbai, India, Dr. Khot performed an internal medicine residency at St. Luke’s-Roosevelt Medical Center (now called Mt. Sinai West/Morningside) in New York City. He then received specialized training in a hematology and oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.In addition to his clinical roles, Dr. Khot is the regional medical director, eastern region at Atlantic Medical Group, overseeing multiple subspecialist clinicians and pediatric practices. He is the associate medical director for GU oncology for community oncology given his special interest in genitourinary cancer. He is a national speaker on bladder and kidney cancers. He serves on several Atlantic Health System committees, including the Overlook Medical Center Blood Bank and Transfusion Committee, as well as the Union Essex Regional Council, AMG Nomination Committee and AMG Health Equity Committee. He regularly lectures and provides teaching rotations for IM and family medicine residents and medical students at Atlantic Health System hospitals.Dr. Ashish Khot is consistently recognized as a “Top Doctor” by New Jersey Monthly magazine by his peers. He is multilingual, speaking fluent Hindi and Marathi, among other languages. Dr. Khot is a participating provider of the Atlantic Accountable Care Organization. Dr. Khot is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia, and Urothelial Cancer. Dr. Khot is board certified in American Board Of Internal Medicine. Dr. Khot is currently accepting new patients.

Manish Dave is a Hematologist Oncology provider practicing medicine in Edison, New Jersey. Dr. Dave is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, Pulmonary Embolism, and Bone Marrow Aspiration. Dr. Dave is board certified in American Board Of Internal Medicine and Internal Medicine.

Aileen Chen is a Hematologist and an Oncologist practicing medicine in Freehold Township, New Jersey. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Chen is board certified in American Board Of Internal Medicine. Dr. Chen is currently accepting new patients.

Jumana Chatiwala is a Hematologist and an Oncologist practicing medicine in Sparta, New Jersey. Dr. Chatiwala is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Chatiwala is currently accepting new patients.

May Matkiwsky is a Hematologist and an Oncologist practicing medicine in Sparta, New Jersey. Dr. Matkiwsky is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Drug-Induced Thrombocytopenia, and Bone Marrow Aspiration. Dr. Matkiwsky is board certified in American Board Of Internal Medicine. Dr. Matkiwsky is currently accepting new patients.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Markowski is board certified in American Board Of Internal Medicine. Dr. Markowski is currently accepting new patients.

Maithili Rao, MD, is a senior health care entrepreneur board-certified in medical oncology and hematology by the American Board of Internal Medicine. She is affiliated with Advanced Care Oncology and Hematology Associates (ACOHA), part of Atlantic Medical Group (AMG). Her professional career includes building a worldclass oncology practice across six counties with 30 practitioners, serving as a medical executive board member at Overlook Hospital, and working as the enterprise medical director of Practice Growth and Integration at Atlantic Medical Group. Dr. Rao has championed an integrated approach to treating cancer and blood disorders, focusing on personalizing patient care, quality, and communication.At each oncology treatment site, Dr. Rao has successfully incorporated palliative care, genetic counseling, dietitians, navigators, social workers, onsite lab and pharmacy services, access to clinical trials, an infusion suite for chemotherapy and immunotherapy, and advanced molecular testing. These integrations enable her to deliver high-quality clinical care and innovative treatment protocols with a unique, holistic, patient-centered approach. She treats all forms of blood disease and cancer, with a special focus on breast cancer.Dr. Rao currently serves as the enterprise medical director of oncology and other specialties for Atlantic Health System (AHS), a multi-award-winning, seven-hospital, nonprofit, integrated health care network in northern New Jersey. AHS has over 400 sites of care, 300 physician practices, and 17,000 team members. Dr. Rao provides clinical and strategic direction for cancer care and has successfully transformed cancer care in New Jersey from a community-focused initiative to a leading oncology center that rivals prestigious competitors in New York City.Dr. Rao has been recognized by the American Cancer Society as a Medical Honoree and has been voted by her peers as New Jersey Monthly’s Top Doctor for over 13 years, among other accolades. Dr. Rao is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Thrombocytopenia, and Bone Marrow Aspiration. Dr. Rao is board certified in American Board Of Internal Medicine. Dr. Rao is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS). Dr. Huannou is board certified in American Board Of Internal Medicine. Dr. Huannou is currently accepting new patients.

Saad Usmani is a Hematologist and an Oncologist practicing medicine in Montvale, New Jersey. Dr. Usmani is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Usmani is currently accepting new patients.

Israel Grossman is an Oncologist practicing medicine in Livingston, New Jersey. Dr. Grossman is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.

Brian Kim is an Oncologist practicing medicine in Englewood, New Jersey. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.